Something exciting is happening in POTS/ME/CFS/Long COVID research right now. Multiple labs and clinicians, working independently, are converging on overlapping mechanisms - neuroinflammation, autonomic and brainstem dysfunction, immune-driven pathways, approached from completely different angles: imaging, immune markers, clinical observation, structural findings.
That kind of convergence is usually a marker of a field reaching scientific maturity. Early-stage fields tend to be scattered and contradictory. A field converging from multiple independent directions toward the same underlying biology is a sign there's real signal to chase. This is what it looks like when a research area starts to click into focus after years of being dismissed or fragmented.
Patients have waited decades for this kind of momentum. Grateful to see so many people pushing in the same direction.